Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF vs PF Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma
NCT01536223Phase 3Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Apr 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in nasopharyngeal carcinoma (NPC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
docetaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01536223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536223.